Reduction of Psoriasis Following Liraglutide Therapy in Terms of PASI and DLQI
1 clinical trials · Condition
◉ Watch Reduction of Psoriasis Following Liraglutide Therapy in Terms of PASI and DLQI
| Record | Firm | Date |
|---|---|---|
| GLP-1 Receptors in Normal Skin and Skin From Patients With Psoriasis (NCT01451905) | University Hospital, Gentofte, Copenhagen | 2011-08-01 |
Track Reduction of Psoriasis Following Liraglutide Therapy in Terms of PASI and DLQI automatically
Every clearance here is in the API, with alerts when new ones post.